Search alternatives:
mean decrease » a decrease (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
50 ms » 500 ms (Expand Search), 50 mg (Expand Search), 50 mm (Expand Search)
mean decrease » a decrease (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
50 ms » 500 ms (Expand Search), 50 mg (Expand Search), 50 mm (Expand Search)
-
621
-
622
-
623
-
624
Shape-Based Reprofiling of FDA-Approved Drugs for the H<sub>1</sub> Histamine Receptor
Published 2012“…Reprofiling of existing drugs to treat conditions not originally targeted is an attractive means of addressing the problem of a decreasing stream of approved drugs. …”
-
625
-
626
-
627
-
628
Cardiac assessments for stroke etiology in young adults and non-young adults.
Published 2022Subjects: -
629
Proportion of stroke subtypes according to age among young adults versus non-young adults.
Published 2022Subjects: -
630
-
631
Vascular assessments for stroke etiology in young adults and non-young adults.
Published 2022Subjects: -
632
-
633
Prevalence of vascular risk factors according to age among young adults versus non-young adults.
Published 2022Subjects: -
634
-
635
-
636
-
637
-
638
-
639
Advancing the science of NOWS research.
Published 2024“…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”
-
640
Protocol measures.
Published 2024“…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”